Abstract
Psoriasis is a hyperproliferative and inflammatory skin disorder of unknown aetiology. A fusion protein composed of human interleukin-2 and fragments of diphtheria toxin (DAB389IL-2), which selectively blocks the growth of activated lymphocytes but not keratinocytes, was administered systemically to ten patients to gauge the contribution of activated T cells to the disease. Four patients showed striking clinical improvement and four moderate improvement, after two cycles of low dose IL-2–toxin. The reversal of several molecular markers of epidermal dysfunction was associated with a marked reduction in intraepidermal CD3+ and CD8+ T cells, suggesting a primary immunological basis for this widespread disorder.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Weinstein, G.D. & Krueger, J.G. An overview of psoriasis. in Therapy of Moderate-to-Severe Psoriasis (eds Weinstein, G. D. & Gottlieb, A.B.) 1–22 (National Psoriasis Foundation, Portland, Oregon 1993).
Vallat, V.P. et al. PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: A possible cellular basis for remittive therapy. J. exp. Med. 180, 283–296 (1994).
Bos, J.D. et al. Predominance of “memory” T cells (CD4+, CDw29+) over “naive” T cells (CD4+, CD45R+) in both normal and diseased human skin. Arch. dermatol. Res. 281, 24–30 (1989).
Gottlieb, A.B. et al. Expression of HLA-DR molecules by keratinocytes and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques. J. exp. Med. 164, 1013–1028 (1986).
Gottlieb, A.B., Chang, C.K., Posnett, D.N., Fanelli, B. & Tarn, J.P. Detection of transforming growth factor alpha in normal, malignant, and hyper-proliferative human keratinocytes. J. exp. Med. 167, 670–675 (1988).
Elder, J.T. et al. Overexpression of transforming growth factor alpha in psoriatic epidermis. Science 243, 811–814 (1989).
Nickoloff, B.J. & Naidu, Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J. Am. Acad. Dermatol. 30, 535–546 (1994).
Henseler, T. & Christophers, E. Psoriasis of early and late onset: Characterization of two types of psoriasis vulgaris. J. Am. Acad. Dermatol. 13, 450–456 (1985)
Baadsgaard, O., Fisher, G., Voorhees, J.J. & Cooper, K.D. The role of the immune system in the pathogenesis of psoriasis. J. invest. Dermatol. 95, 32S–34S (1990).
Chang, J.C.C. et al. CD8+ T cells in psoriatic lesions preferentially use T-cell receptor Vβ3 and/or Vβ13.1 genes. Proc. natn. Acad. Sci. U.S.A. 91, 9282–9286 (1994).
Gottlieb, A.B. & Krueger, J.G. Role of T-lymphocytes (in psoriasis pathogenesis). in Psoriasis (ed. Dubertret, L.) 63–71 (ISED Publishing Co, Brescia, Italy, 1994)
Prinz, J.C. et al. T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products. Eur. J. Immun. 24, 593–598 (1994).
Bata-Csorgo, Z., Hammerberg, C., Voorhees, J.J. & Cooper, K.D. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. J. clin. Invest. 95, 317–327 (1995).
Krueger, J.G. & Gottlieb, A.B. Growth factors, cytokines and eicosanoids (in psoriasis pathogenesis). in Psoriasis (ed. Dubertret, L.) 18–28 (ISED Publishing Co., Brescia, Italy, 1994)
Baker, B.S. et al. The effects of cyclosporin A on T lymphocyte and dendritic cell sub-populations in psoriasis. Br. J. Dermatol. 116, 503–510 (1987).
Rizova, H. et al. The effect of anti-CD4 monoclonal antibody treatment on immunological changes in psoriatic skin. J. dermatol. Sci. 7, 1–13 (1994).
Ackerman, C. et al. Recalcitrant psoriasis and pyoderma gangrenosum treated with FK506. J. invest. Dermatol. 96, 536 (1991).
Petzelbauer, P., Stingl, G., Wolff, K. & Volc-Platzer, B. Cyclosporin A suppresses ICAM-1 expression by papillary endothelium in healing psoriatic plaques. J. invest. Dermatol. 96, 362–369 (1991).
Gottlieb, A.B. et al. Studies of the effect of cyclosporine in psoriasis in vivo: Combined effects on activated T lymphocytes and epidermal regenerative maturation. J. invest. Dermatol. 98, 302–309 (1992).
Khandke, L. et al. Cyclosporine in psoriasis treatment: Inhibition of keratinocyte cell-cycle progression in G1 independent of effects on transforming growth factor-alpha/epidermal growth factor receptor pathways. Arch. Dermatol. 127, 1172–1179 (1991).
Williams, D.P. et al. Diphtheria toxin receptor binding domain substitution with interleukin-2: Genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein. Protein Engng 1, 493–498 (1987).
Waters, C.A. et al. Interleukin 2 receptor-targeted cytotoxicity. Receptor binding requirements for entry of a diphtheria toxin-related interleukin 2 fusion protein into cells. Eur. J. Immun. 20, 785–791 (1990).
Waldman, T.A. The IL-2/IL-2 receptor system: a target for rational immune intervention. Immun. Today 14, 264–270 (1993).
Shaw, J.P. et al. Cytotoxic properties of DAB486EGF and DAB389EGF, epidermal growth factor (EGF) receptor-targeted fusion toxins. J. biol. Chem. 266, 21118–21124 (1991).
Mansbridge, J.N. & Knapp, A.M. Changes in keratinocyte maturation during wound healing. J. invest. Dermatol. 89, 253–263 (1987).
Valdimarsson, H., Baker, B.S., Jonsdottir, I., Powles, A. & Fry, L. Psoriasis: A T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immun. Today 16, 145–149 (1995).
Paukkonen, K., Naukkarinen, A. & Horsmanheimo, M. The development of manifest psoriatic lesions in linked with the invasion of CD8+ T cells and CD11c+ macrophages into the epidermis. Arch. Dermatol. Res. 284, 375–379 (1992).
Onuma, A. Immunohistochemical studies of infiltrating cells in early and chronic lesions of psoriasis. J. Dermatol. 21, 223–232 (1994).
Gottlieb, S.L. et al. Short-contact anthralin treatment augments therapeutic efficacy of cyclosporine in psoriasis. A clinical and pathologic study. J. Am. Acad. Dermatol. (in the press).
Hammer, R.E., Maika, S.D., Richardson, J.A., Tang, J.P. & Taurog, J.D. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta2m: An animal model of HLA-B27-associated human disorders. Cell 63, 1099–1112 (1990).
Carnaud, C. & Bach, J-F. Cellular basis of T-cell autoreactivity in autoimmune diseases. Immun. Res. 12, 131–148 (1993).
Bacha, P.L. et al. Impact of interleukin-2-receptor-targeted cytotoxins on a unique model of murine interleukin-2-receptor-expressing malignancy. Int. J. Cancer 49, 96–101 (1991).
Krane, J.F. et al. Increased dermal expression of platelet-derived growth factor receptors in growth-activated skin wounds and psoriasis. J. invest. Dermatol. 96, 983–986 (1991).
Tomfohrde, J. et al. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 264, 1141–1145 (1994).
LeMaistre, C.F. et al. Phase I trial of an interleukin-2 (IL-2) fusion toxin (DAB486IL-2) in hematologic malignancies expressing the IL-2 receptor. Blood 79, 2547–2554 (1992).
Fredriksson, T. & Pettersson, U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 157, 238–244 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gottlieb, S., Gilleaudeau, P., Johnson, R. et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1, 442–447 (1995). https://doi.org/10.1038/nm0595-442
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0595-442
This article is cited by
-
Role of Pro-inflammatory and Anti-inflammatory Cytokines in Pathophysiology of Psoriasis
Current Oral Health Reports (2022)
-
Psoriasis therapy by Chinese medicine and modern agents
Chinese Medicine (2018)
-
The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis
Nature Immunology (2018)
-
TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis
Nature Communications (2018)
-
Autoimmunity in Psoriasis: Evidence for Specific Autoantigens
Current Dermatology Reports (2017)